BOSTON (AP) _ Vertex Pharmaceuticals Inc. (VRTX) on Wednesday reported third-quarter net income of $128.7 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Boston-based company said it had net income of 50 cents. Earnings, adjusted for stock ...
BOSTON (AP) _ Vertex Pharmaceuticals Inc. (VRTX) on Wednesday reported second-quarter net income of $207.4 million.
On a per-share basis, the Boston-based company said it had profit of 80 cents. Earnings, adjusted for one-time gains and costs, came to 94 cents per share.
The results ...
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday:
Morgan Stanley, up $1.48 to $46.62
The investment bank had a solid second quarter and its trading desks did better than its competitors.
McCormick & Co., down 56 cents to $164.85
The spice ...
- BusinessWireX-Chem and Vertex Expand Existing PartnershipJanuary 4, 2019
- Globe NewswireCRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell DiseaseJanuary 4, 2019
- BusinessWireVertex and Arbor Biotechnologies Establish Collaboration to Discover Novel Proteins to Advance Discovery of Gene-Editing TherapiesJanuary 3, 2019
- BusinessWireVertex to Present at the J.P. Morgan Healthcare Conference on January 7January 2, 2019
- BusinessWireNACD New England Chapter Names Leaders in Corporate Governance as 2019 ‘Director of the Year’ HonoreesDecember 20, 2018